Testing effectiveness (Phase 2)UnknownNCT03612232What this trial is testingCabozantinib in Advanced Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma Wuerzburg University Hospital 37
Early research (Phase 1)Study completedNCT01772004What this trial is testingAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)Who this might be right forSolid Tumors EMD Serono Research & Development Institute, Inc. 1,756
Early research (Phase 1)Looking for participantsNCT04119024What this trial is testingGene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsWho this might be right forMetastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more Anusha Kalbasi 18
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Looking for participantsNCT06333314What this trial is testingDostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSIWho this might be right forPancreatic AdenocarcinomaAmpulla of Vater CarcinomaAdrenocortical Carcinoma+5 more UNICANCER 120
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Ended earlyNCT03145909What this trial is testingA Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)Who this might be right forAdvanced Solid Tumors Cancer AbbVie 19
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Very early researchStudy completedNCT00436410What this trial is testingTumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerWho this might be right forAdrenocortical CarcinomaBreast CancerColorectal Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Study completedNCT00848016What this trial is testingGossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By SurgeryWho this might be right forRecurrent Adrenocortical CarcinomaStage III Adrenocortical CarcinomaStage IV Adrenocortical Carcinoma National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Looking for participantsNCT06006013What this trial is testingCabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical CancerWho this might be right forLocally Advanced Adrenal Cortex CarcinomaAdrenal Cortical CarcinomaStage III Adrenal Cortex Carcinoma+2 more Emory University 21
Testing effectiveness (Phase 2)UnknownNCT00637637What this trial is testingExternal-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesWho this might be right forCancer Oncology Institute of Southern Switzerland 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732What this trial is testingPembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticWho this might be right forAdvanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more M.D. Anderson Cancer Center 157
Testing effectiveness (Phase 2)Looking for participantsNCT05286814What this trial is testingPDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical CarcinomaWho this might be right forMetastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Cancer+10 more National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Looking for participantsNCT06900595What this trial is testingTesting the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical CancerWho this might be right forLocally Advanced Adrenal Cortical CarcinomaMetastatic Adrenal Cortical CarcinomaRecurrent Adrenal Cortical Carcinoma+3 more National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT03370718What this trial is testingCabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical CarcinomaWho this might be right forMetastatic Carcinoma in the Adrenal CortexStage III Adrenal Cortex Carcinoma AJCC v8Stage IV Adrenal Cortex Carcinoma AJCC v8+1 more M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Ended earlyNCT00778817What this trial is testingIMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by SurgeryWho this might be right forRecurrent Adrenocortical CarcinomaStage III Adrenocortical CarcinomaStage IV Adrenocortical Carcinoma National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00002608What this trial is testingCombination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsWho this might be right forAdrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more Ottawa Regional Cancer Centre 30
Testing effectiveness (Phase 2)Ended earlyNCT02720484What this trial is testingNivolumab in Treating Patients With Metastatic Adrenocortical CancerWho this might be right forMetastatic Carcinoma in the Adrenal CortexRecurrent Adrenal Cortex CarcinomaStage III Adrenal Cortex Carcinoma+1 more Northwestern University 10